Skip To Main Content
Peppino Mirabelli on Muck Rack

Peppino Mirabelli

As seen in: Nature, Wiley Online Library, MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Peppino

Contact Peppino, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Gelofusine as alternative to Dextran40‐based solution for washing cryopreserved hematopoietic stem cell products prior to infusion: Validation and application to clinical practice

|
By Peppino Mirabelli, Stefania Nappo, Mario Toriello, Giovanna Maisto
| Wiley Online Library Verified
Supporting Information Filename Description trf18272-sup-0001-TableS1.xlsxExcel 2007 spreadsheet , 17.6 KB Table S1. Characteristics of the 93 HSC samples used for transplantation. For each sample, the table includes the HSC source (PBSC or BM; autologous or allogeneic), patient age and weight, sample volume, total DMSO dose, cryopreservation duration, TNC and CD34+ cell recovery and viability after washing, blood culture results, and infusion reactions.
Open in Who Shared Issue with article?

Circulating Biomarkers for Monitoring Chemotherapy-Induced Cardiotoxicity in Children

|
By Maria Flavia Savarese, Peppino Mirabelli, Luigia Meo, Carmen Munno
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared View Duplicates (457) Issue with article?

miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase

|
By Vito Alessandro Lasorsa, Francesca Maria Orlandella, Raffaela Mariarosaria Mariniello, Peppino Mirabelli
| Nature Verified
Abstract Background Aberrant expression of microRNAs (miR) has been proposed as non-invasive biomarkers for breast cancers. The aim of this study was to analyse the miR-622 level in the plasma and in tissues of breast cancer patients and to explore the role of miR-622 and its target, the NUAK1 kinase, in this context. Methods miR-622 expression was analysed in plasma and in tissues samples of breast cancer patients by q-RT-PCR.
Open in Who Shared Issue with article?
See all 3 articles